Phlegmasia cerulea dolens is the most severe form of deep venous thrombosis, characterized by massive iliofemoral venous thrombosis extending into collateral veins, resulting in near-complete venous outflow obstruction with the classic triad of severe pain, massive edema, and cyanosis. It carries an amputation rate of up to 50% and mortality of 20–40%. [1-3] PCD exists on a spectrum: distal DVT → proximal DVT → phlegmasia alba dolens (white, swollen, painful leg with spared collaterals) → phlegmasia cerulea dolens (blue, swollen, painful leg with collateral involvement) → venous gangrene. [2] PCD is preceded by phlegmasia alba dolens in 50–60% of cases. [2]
1. History
- Onset and progression: Acute onset of severe, unrelenting limb pain with rapid swelling and color change (white → blue/purple); may evolve over hours to days [4-5]
- Symptom characterization: Pain is typically excruciating and may be refractory to opioids; IV lidocaine has been used as rescue analgesia [3]
- Laterality: Left lower extremity predominates (due to May-Thurner anatomy) [1][6]
- Triggers: Recent immobilization, surgery, hospitalization, prolonged travel, malignancy diagnosis, pregnancy/postpartum, central venous catheter placement [1-2][7]
- Associated symptoms: Paresthesias, motor weakness (suggests compartment syndrome), dyspnea/chest pain (concurrent PE in up to 30%) [2-3]
- Important negatives: Absence of trauma, absence of arterial disease symptoms (claudication), no prior similar episodes
2. Alarm Features
- Cyanosis progressing to dusky/mottled skin — suggests impending venous gangrene [8]
- Loss of pedal pulses — pulses remain palpable in only ~50% of PCD patients; loss indicates severe arterial compromise from elevated tissue pressures [8]
- Motor deficit or paralysis — compartment syndrome; compartment pressures can increase 16-fold within 6 hours [3]
- Hemodynamic instability — massive fluid sequestration into the limb causes hypovolemia, hypotension, and circulatory shock [2][8]
- Bullae, skin necrosis, or frank gangrene — venous gangrene complicates 60–64% of PCD cases and carries >33% mortality [8]
- Bilateral limb involvement — associated with significantly worse prognosis (higher amputation and death rates) [1]
3. Medications
- Immediate: IV unfractionated heparin (UFH) — weight-based bolus and infusion; preferred for titrability and short half-life in a patient who may need procedural intervention [7-8]
- Caution with warfarin: Initiation of warfarin in the setting of PCD (especially with underlying malignancy or HIT) can precipitate venous gangrene via protein C depletion [8-9]
- Heparin-induced thrombocytopenia (HIT): Must be considered as both a cause and complication; if suspected, switch to a non-heparin anticoagulant (argatroban, bivalirudin) [8-9]
- Thrombolytics: Catheter-directed tPA for cases not responding to anticoagulation; contraindications include active bleeding, recent surgery, intracranial pathology [8][10]
- Medications contributing to VTE risk: Oral contraceptives, hormone replacement therapy, tamoxifen, chemotherapy agents, erythropoiesis-stimulating agents
4. Diet
- Not a primary management consideration in the acute setting
- Aggressive IV fluid resuscitation is critical to counteract massive third-spacing into the affected limb and prevent circulatory collapse [4][7]
- Long-term: Standard VTE dietary considerations if placed on warfarin (vitamin K consistency); DOACs have fewer dietary interactions
5. Review of Systems
- Cardiovascular: Chest pain, dyspnea, palpitations (concurrent PE)
- Neurologic: Paresthesias, numbness, motor weakness in the affected limb (compartment syndrome)
- Constitutional: Fever, weight loss, night sweats (underlying malignancy)
- GI/GU: Abdominal/pelvic pain, hematuria, changes in bowel habits (pelvic mass compressing iliac veins)
- Hematologic: History of easy bruising, prior clots, family history of clotting disorders
- Skin: Bullae formation, skin breakdown, color changes
6. Collateral History and Family History
- Collateral: Recent hospitalization, immobilization, surgery, central line placement, cancer treatment history, medication list (especially anticoagulants held)
- Family history: VTE, inherited thrombophilias (Factor V Leiden, prothrombin gene mutation, protein C/S deficiency, antithrombin deficiency)
- Social context: Recent long-distance travel, IV drug use, smoking history [2]
7. Risk Factors
- Malignancy — most common association; reproductive system cancers are the most frequent malignancy type [1][11]
- Venous structural abnormalities — May-Thurner syndrome (left common iliac vein compression by right common iliac artery) [1][6]
- Prior VTE [1]
- Hypercoagulable states — antiphospholipid syndrome, HIT, DIC, inherited thrombophilias [9][12]
- Recent surgery or trauma, postoperative state [7]
- Immobilization — prolonged travel, hospitalization [2]
- Pregnancy/postpartum
- COVID-19 — reported association with severe VTE including PCD [13]
- Extrinsic venous compression — pelvic masses, uterine fibroids, retroperitoneal pathology [4]
8. Differential Diagnosis
- Acute arterial limb ischemia — distinguished by pallor (not cyanosis), absent pulses, no massive edema; the 6 P's (pain, pallor, pulselessness, poikilothermia, paresthesias, paralysis) [14-15]
- Necrotizing fasciitis — erythema, crepitus, systemic toxicity, skin necrosis; lacks the massive venous congestion pattern
- Compartment syndrome (primary) — pain out of proportion, tense compartments; in PCD, compartment syndrome is secondary
- Acute DVT (non-phlegmasia) — swelling and pain without cyanosis or limb-threatening ischemia
- Cellulitis/abscess — erythema, warmth, fever; typically not cyanotic
- Symmetric peripheral gangrene/purpura fulminans — bilateral, symmetric acral necrosis in critically ill patients (sepsis, DIC); usually without DVT [9]
- Atheroembolism — blue toe syndrome, livedo reticularis, preserved pulses
9. Past Medical History
- Prior DVT/PE episodes
- Known malignancy (especially pelvic/abdominal)
- Known thrombophilia or hypercoagulable state
- Recent surgery, trauma, or prolonged immobilization
- HIT history
- Chronic venous insufficiency
- Autoimmune conditions (antiphospholipid syndrome, lupus)
10. Physical Exam
- Inspection: Massively swollen, tense, cyanotic (blue-purple) limb; may have bullae or areas of skin necrosis; sharp demarcation at the inguinal region [2][4-5]
- Palpation: Tense, non-pitting edema; exquisitely tender; check for crepitus (rule out necrotizing fasciitis)
- Pulses: Pedal pulses present in ~50% of cases; absent pulses indicate severe compromise [8]
- Neurovascular: Assess sensation and motor function — loss suggests compartment syndrome [3]
- Vital signs: Tachycardia, hypotension (from fluid sequestration and hypovolemia); tachypnea (concurrent PE) [8]
- Compartment assessment: Tense, woody compartments; pain with passive stretch
- Contralateral limb: Assess for bilateral DVT [2]
11. Lab Studies
- CBC with differential — assess for thrombocytopenia (HIT, DIC), leukocytosis
- Comprehensive metabolic panel — renal function (contrast planning, rhabdomyolysis), electrolytes (hyperkalemia from tissue ischemia)
- Coagulation studies — PT/INR, aPTT, fibrinogen (baseline before thrombolysis) [16]
- D-dimer — will be markedly elevated but is nonspecific; not needed to confirm diagnosis when clinical presentation is obvious [17]
- Lactate — marker of tissue ischemia and systemic hypoperfusion
- CK (creatine kinase) — elevated with compartment syndrome/rhabdomyolysis
- ABG/VBG — metabolic acidosis (lactic acidosis from limb ischemia; metabolic acidosis is a primary cause of death) [1]
- Type and screen — anticipate need for blood products
- Thrombophilia workup — consider antiphospholipid antibodies, HIT panel (anti-PF4), protein C/S, antithrombin III (timing-dependent; some deferred to outpatient) [12]
- Troponin/BNP — if concurrent PE suspected
12. Imaging
- First-line: Duplex ultrasonography — rapid, bedside, confirms extensive DVT; POCUS can detect rapidly evolving thrombus [2][6]
- CT venography (CTV) — defines full extent of thrombosis (iliocaval involvement in 93% of cases), identifies underlying compression (May-Thurner), pelvic masses, and occult malignancy [1][5][14]
- CT angiography — if arterial ischemia is also suspected or to differentiate from acute arterial occlusion [6][14]
- Conventional venography — gold standard for mapping thrombus extent; typically performed at time of catheter-directed intervention [5]
- Multimodal imaging recommended to identify underlying malignancies and venous structural abnormalities [1]
- Imaging should not delay treatment when clinical diagnosis is clear
13. Special Tests
- Compartment pressure measurement — calf pressures ≥30 mm Hg after venous outflow restoration warrant fasciotomy consideration; pressures of 47–56 mmHg documented in PCD [8][18]
- Point-of-care ultrasound (POCUS) — critical in the ED for rapid DVT detection; can identify rapidly evolving thrombus even when formal duplex is initially negative [6]
- Ankle-brachial index (ABI) — perfusion pressure <50 mmHg at the ankle indicates limb ischemia [15]
- Continuous-wave Doppler — assess for arterial flow in the affected limb
14. ECG
- Indications: Obtain in all patients to evaluate for concurrent PE and hemodynamic compromise
- Findings suggesting PE: Sinus tachycardia, right heart strain pattern (S1Q3T3), right axis deviation, right bundle branch block, T-wave inversions in anterior leads (V1–V4)
- Baseline ECG also important before procedural intervention
15. Assessment
Clinical staging (adapted from the literature): [1-2]
- Stage I: Edema without cyanosis (phlegmasia alba dolens)
- Stage II: Edema with cyanosis but no gangrene (phlegmasia cerulea dolens)
- Stage III: Venous gangrene — irreversible tissue necrosis; carries the highest mortality and amputation rates [1]
PCD is a vascular emergency. The pathophysiology involves massive venous outflow obstruction → venous hypertension → massive fluid sequestration into the limb (up to several liters) → arteriolar collapse when tissue pressure exceeds critical closing pressure → limb ischemia → gangrene. [2][8][12] Concurrent PE occurs in up to 30% of cases. [2] Overall mortality is approximately 18.75–40%, primarily from metabolic acidosis and multiorgan failure. [1-2]
16. Treatment Plan
Immediate stabilization
- Large-bore IV access, aggressive fluid resuscitation — counteract hypovolemia from massive third-spacing [4][7]
- Limb elevation [7]
- IV unfractionated heparin — bolus and continuous infusion; initiate immediately [7-8]
Definitive treatment — early thrombus removal (Grade 1A recommendation, SVS/AVF): [8]
- Catheter-directed thrombolysis (CDT) and/or pharmacomechanical thrombectomy — strongly recommended as first-line for limb-threatening venous ischemia; endovenous debulking techniques reduced amputation and death by 70% compared with anticoagulation alone [1][8]
- Surgical thrombectomy — reserved for patients with contraindications to thrombolysis [7-8]
- If no clinical improvement with anticoagulation within 6–12 hours, escalate to catheter-directed intervention [4]
Adjunctive measures
- IVC filter — consider if anticoagulation is contraindicated or PE risk is high [10]
- Iliac vein stenting — if underlying venous compression (May-Thurner) is identified [4][6]
- Fasciotomy — only if compartment pressures remain >30 mmHg despite successful venous outflow restoration; should not precede or replace thrombus removal [8]
- IV lidocaine — may be considered for refractory pain [3]
Anticoagulation transition
17. Disposition
- All patients require admission, typically to the ICU or step-down unit for hemodynamic monitoring, serial neurovascular checks, and potential procedural intervention [1][4]
- Immediate vascular surgery and/or interventional radiology consultation is mandatory [19-20]
- Transfer to a facility with endovascular capability if not available locally
- Hematology consultation — if HIT, DIC, or thrombophilia is suspected [19]
- Surgical oncology — if underlying malignancy is identified
18. Follow Up / Return Precautions
- Inpatient: Serial neurovascular exams every 1–2 hours; monitor for compartment syndrome, reperfusion injury, and rhabdomyolysis; repeat imaging to assess thrombus resolution [19]
- Post-discharge: Vascular surgery follow-up within 1–2 weeks; anticoagulation management; compression therapy for symptom control [19]
- Malignancy screening: Multimodal imaging recommended to identify occult malignancy, as it is the most common underlying etiology [1]
- Post-thrombotic syndrome (PTS): High risk; monitor with Villalta scale; early compression and ambulation may reduce severity [19]
- Return precautions: Worsening swelling, color change, new pain, numbness/weakness, chest pain, shortness of breath, signs of bleeding (if on anticoagulation)
- Expected course: With prompt intervention, limb salvage is achievable; delayed treatment dramatically increases amputation and mortality risk [1][5]
References
1. Unraveling the Risk Factors, Prognostic Predictors, and Evolving Therapeutic Approaches for Phlegmasia Cerulea Dolens Over 30 Years. — Feng Y, Fan G, Song W, et al. Annals of Medicine. 2025.
2. Rare Case of Unilateral Phlegmasia Cerulea Dolens With Bilateral Deep Vein Thrombosis at a Community Military Hospital Emergency Department. — Lipe DN, Cuthbert D. Military Medicine. 2017.
3. Phlegmasia Cerulea Dolens Causing Compartment Syndrome. — Aydemir B, Hoyle C, Hakmeh W. The American Journal of Emergency Medicine. 2022.
4. Iliac Vein Stenting and Thrombectomy Result in Limb Salvage in Phlegmasia Caerulea Dolens as a Result of Heavy Fibroid Burden. — Zamin SA, Mitchell M. The American Surgeon. 2024.
5. Successful Treatment of Phlegmasia Cerulea Dolens With Percutaneous Thrombectomy and Catheter-Directed Thrombolysis: A Case Report. — Chang CT, Chang CD. Medicine. 2022.
6. From Negative Duplex to Phlegmasia in Minutes: Bedside POCUS Identifies Rapid Thrombosis Unmasking Underlying May-Thurner Syndrome. — Unger A. Journal of Clinical Ultrasound : JCU. 2026.
7. Advances in the Treatment of Phlegmasia Cerulea Dolens. — Hood DB, Weaver FA, Modrall JG, Yellin AE. American Journal of Surgery. 1993.
8. Early Thrombus Removal Strategies for Acute Deep Venous Thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum. — Meissner MH, Gloviczki P, Comerota AJ, et al. Journal of Vascular Surgery. 2012.
9. Ischemic Limb Gangrene with Pulses. — Warkentin TE. The New England Journal of Medicine. 2015.
10. Cancer-Associated Venous Thromboembolic Disease. — Updated 2026-05-05. National Comprehensive Cancer Network.
11. Phlegmasia Cerulea Dolens Following Internal Hemipelvectomy: Case Report and Literature Review. — Butterworth JA, Huynh TT, Lewis VO, Chang EI. Injury. 2020.
12. Fulminant Phlegmasia Cerulea Dolens With Concurrent Cholangiocarcinoma and a Lupus Anticoagulant: A Case Report and Review of the Literature. — Chang G, Yeh JJ. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 2014.
13. A Case of Phlegmasia Cerulea Dolens in a Patient With COVID-19, Effectively Ttreated With Fasciotomy and Mechanical Thrombectomy. — Gutierrez JR, Volteas P, Skripochnik E, Tassiopoulos AK, Bannazadeh M. Annals of Vascular Surgery. 2022.
14. ACR Appropriateness Criteria® Sudden Onset of Cold, Painful Leg: 2023 Update. — Browne WF, Sung J, Majdalany BS, et al. Journal of the American College of Radiology : JACR. 2023.
15. Acute Limb Ischemia. — Creager MA, Kaufman JA, Conte MS. The New England Journal of Medicine. 2012.
16. The Society for Vascular Surgery’s Multidisciplinary Management Guide on the Perioperative Care of Patients with Vascular Disease. — Rabih Chaer MD MS, Cassius Iyad Ochoa Chaar MD MS, Theodore Yuo MD, et al Society for Vascular Surgery (2023). 2023.
17. Venous Thromboembolism. — Khan F, Tritschler T, Kahn SR, Rodger MA. Lancet. 2021.
18. Intramuscular Pressure in the Lower Leg in Deep Vein Thrombosis and Phlegmasia Cerulae Dolens. — Qvarfordt P, Eklöf B, Ohlin P. Annals of Surgery. 1983.
19. Revisiting the Open Vein Hypothesis to Reduce the Postthrombotic Syndrome: Implications for Multidisciplinary Care and Research: A Scientific Statement From the American Heart Association. — Li W, Vedantham S, Jaffer FA, et al. Circulation. 2025.
20. Society of Interventional Radiology Position Statement on the Endovascular Management of Acute Iliofemoral Deep Vein Thrombosis. — Vedantham S, Desai KR, Weinberg I, et al. Journal of Vascular and Interventional Radiology : JVIR. 2023.